Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Mantle Cell Lymphoma

Breast Cancer

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Mantle Cell Lymphoma

Pipeline Updates Advance Paradigms Across Lymphomas

Matthew S. McKinney, MD, discusses exciting treatment advances made in Hodgkin and non-Hodgkin lymphoma, specifically the compelling research in follicular lymphoma and mantle cell lymphoma.
Read More >>

MCL Landscape Rapidly Evolving With Promising Approaches on Horizon

Small Molecule Shows Marked Activity Against Ibrutinib-Resistant MCL

MCL Treatment Paradigm Expands With Novel Combos

Clinical Outcomes Consistent in MCL Irrespective of Induction Regimen

Clinical Factors in MCL Successful in Guiding Watch-and-Wait Strategy

View More Stories >>

View Conference Coverage

2019 State of the Science Summit on Hematologic Malignancies in Pittsburgh

2019 State of the Science Summit on Hematologic Malignancies in Seattle

15th International Conference on Malignant Lymphoma

2019 European Hematology Association Congress

2019 ASCO Annual Meeting

$Dr. Karmali on Novel Agents in Relapsed/Refractory MCL$

Dr. Karmali on Novel Agents in Relapsed/Refractory MCL

$Dr. Wang on Challenges Treating Patients With Relapsed/Refractory MCL$

Dr. Wang on Challenges Treating Patients With Relapsed/Refractory MCL

Dr. Karmali on Ibrutinib Maintenance Following Induction in Untreated MCL

Dr. Fenske Discusses Targets Under Evaluation in MCL

OncLive houses thousands of videos that provide updates and information.
See more Videos

Highlights from ASH 2017: Mantle Cell Lymphoma

Investigational Treatment in Mantle Cell Lymphoma

Future Therapy: Bruton's TKI Containing Combinations in MCL

Allogeneic Transplantation in Mantle Cell Lymphoma

Acalabrutinib in Relapsed Mantle Cell Lymphoma

Ibrutinib in Relapsed Mantle Cell Lymphoma

Understanding Relapse in Mantle Cell Lymphoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

New and Emerging BTK Inhibitors in Mantle Cell Lymphoma

First-Generation BTK Inhibition in Mantle Cell Lymphoma

Advice for Future Management of Mantle Cell Lymphoma

Non-BTKi Agents' Role in Mantle Cell Lymphoma

MCL: Novel BTK Inhibitor Combination Strategies

$Identifying Unmet Needs in Relapsed/Refractory MCL$

Differentiating BTK Inhibitor Mechanisms of Action in MCL

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Ibrutinib in Relapsed Mantle Cell Lymphoma

Drs Danilov, Goy, Leonard, Pagel, and Schuster, discuss ibrutinib (Imbruvica) as a treatment in relapsed mantle cell lymphoma. View Now

Treatments for Relapsed Mantle Cell Lymphoma

Brad S. Kahl, MD, and Richard R. Furman, MD, explain available treatment options for relapsed mantle cell lymphoma. View Now

Featured Video

Advances in BRAF-Targeted Therapy for Metastatic Melanoma

Novel Combination Approaches for Metastatic Kidney Cancer

Geoffrey Thomas Gibney, MD; Ryan J. Sullivan, MD; Hussein A. Tawbi, MD, discuss advances in BRAF-targeted therapy for patients with metastatic melanoma. View now

OncLive News Network On Location: In Chicago